Illumina reagent chemistry kits
Ended Awarded Last action
- Contract number
- 75F40123F19001
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $162,137
Award facts
- Contract value 100% obligated
- $162,136.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | -$2,644 | |
| Original award | $164,780 |
About this award
The Food and Drug Administration (FDA) awarded a delivery order contract to Illumina, Inc. for illumina reagent chemistry kits, with a ceiling value of $162,136.75. The contract, which is structured as a firm fixed price delivery order with no set-aside designation, was awarded on January 30, 2023, and is scheduled for completion by October 21, 2025. Performance will take place in Laurel, Maryland. This delivery order leverages Illumina's specialized expertise as a leading biotechnology company headquartered in San Diego, California, and manufacturer of advanced DNA and RNA sequencing instruments, reagents, and related consumables that support genomic analysis and scientific research across multiple federal agencies.
The reagent chemistry kits procured under this delivery order support the FDA's laboratory capabilities for genetic sequencing and genomic analysis work. Illumina's reagent kits are integral components of its comprehensive genomic sequencing platforms, enabling DNA and RNA analysis across various applications including research, diagnostics, and quality assurance functions. The FDA's procurement of these specialized reagents reflects the agency's reliance on cutting-edge biotechnology tools to advance its public health mission, including food and drug safety assessments and regulatory science initiatives. Illumina has established itself as a trusted supplier to federal agencies, holding multiple prime contracts and a significant $45 million indefinite delivery contract with the U.S. Department of Agriculture.
Quick answers
Who was awarded contract 75F40123F19001?
75F40123F19001 was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on January 30, 2023.
How much is contract 75F40123F19001 worth?
The government has obligated $162,137 on 75F40123F19001.
Is contract 75F40123F19001 an order under another contract?
Yes. 75F40123F19001 is a delivery order under 75F40123D00001, an indefinite delivery contract.
Was contract 75F40123F19001 competed?
The extent of competition for 75F40123F19001 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award